Title:
短鎖ペプチド抗腫瘍ワクチンを用いて早期のＴメモリー応答を誘発する方法。
Document Type and Number:
Japanese Patent JP6654207
Kind Code:
B2
Abstract:
The present invention relates to a therapeutic peptide T specific immune therapy for use in the treatment of a cancer of an HLA-A2 (Human Leukocyte Antigen A2) positive patient, said treatment comprises a priming period consisting in two to three administrations of said therapeutic peptide T specific immune therapy, thereby inducing a memory T cell response.
Inventors:
Dominic Costantini
Application Number:
JP2017567729A
Publication Date:
February 26, 2020
Filing Date:
June 29, 2015
Export Citation:
Assignee:
OSE Immunotherapeutics
International Classes:
A61K39/00; A61K9/10; A61K31/282; A61K31/337; A61K31/407; A61K31/4188; A61K31/4545; A61K31/4745; A61K31/475; A61K31/506; A61K31/513; A61K31/517; A61K31/519; A61K31/5377; A61K31/573; A61K31/675; A61K31/7048; A61K33/24; A61K39/39; A61K39/395; A61K45/00; A61P35/00; A61P37/04; A61P43/00
Domestic Patent References:
| JP2006526628A |
Other References:
J Clin Oncol.,2008年 9月20日,26(27),p.4418-4425
Immunity,1994年12月,1,p.751-761
Immunity,1994年12月,1,p.751-761
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mitsuhiro
Tatsuhiko Abe
Shinya Mitsuhiro
Tatsuhiko Abe